These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 33327002)

  • 1. Optimal allocation of limited test resources for the quantification of COVID-19 infections.
    Chatzimanolakis M; Weber P; Arampatzis G; Wälchli D; Kičić I; Karnakov P; Papadimitriou C; Koumoutsakos P
    Swiss Med Wkly; 2020 Dec; 150():w20445. PubMed ID: 33327002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. One-house one-person testing: Strategical plan to limit COVID-19 spread in stage three in the developing world.
    Ali SME
    Infect Control Hosp Epidemiol; 2021 Jan; 42(1):117-118. PubMed ID: 32372726
    [No Abstract]   [Full Text] [Related]  

  • 3. State-specific projection of COVID-19 infection in the United States and evaluation of three major control measures.
    Chen S; Li Q; Gao S; Kang Y; Shi X
    Sci Rep; 2020 Dec; 10(1):22429. PubMed ID: 33380729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergistic interventions to control COVID-19: Mass testing and isolation mitigates reliance on distancing.
    Howerton E; Ferrari MJ; Bjørnstad ON; Bogich TL; Borchering RK; Jewell CP; Nichols JD; Probert WJM; Runge MC; Tildesley MJ; Viboud C; Shea K
    PLoS Comput Biol; 2021 Oct; 17(10):e1009518. PubMed ID: 34710096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Containing pandemics through targeted testing of households.
    Voigt A; Martyushenko N; Karlsen E; Hall M; Nyhamar K; Omholt SW; Almaas E
    BMC Infect Dis; 2021 Jun; 21(1):548. PubMed ID: 34107917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tracking COVID-19 infections: time for change.
    Dean N
    Nature; 2022 Feb; 602(7896):185. PubMed ID: 35136224
    [No Abstract]   [Full Text] [Related]  

  • 7. International travel during the COVID-19 pandemic: implications and risks associated with 'travel bubbles'.
    Sharun K; Tiwari R; Natesan S; Yatoo MI; Malik YS; Dhama K
    J Travel Med; 2020 Dec; 27(8):. PubMed ID: 33009813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Forecasting hospital demand in metropolitan areas during the current COVID-19 pandemic and estimates of lockdown-induced 2nd waves.
    Capistran MA; Capella A; Christen JA
    PLoS One; 2021; 16(1):e0245669. PubMed ID: 33481925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Social mixing and risk exposures for SARS-CoV-2 infections in elderly persons.
    Haag C; Höglinger M; Moser A; Hämmig O; Puhan M; von Wyl V
    Swiss Med Wkly; 2020 Nov; 150():w20416. PubMed ID: 33277915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tracking the time course of reproduction number and lockdown's effect on human behaviour during SARS-CoV-2 epidemic: nonparametric estimation.
    Pillonetto G; Bisiacco M; Palù G; Cobelli C
    Sci Rep; 2021 May; 11(1):9772. PubMed ID: 33963235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Data-driven inference of the reproduction number for COVID-19 before and after interventions for 51 European countries.
    Karnakov P; Arampatzis G; Kičić I; Wermelinger F; Wälchli D; Papadimitriou C; Koumoutsakos P
    Swiss Med Wkly; 2020 Jul; 150():w20313. PubMed ID: 32677705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simple Questionnaires to Improve Pooling Strategies for SARS-CoV-2 Laboratory Testing.
    Schneitler S; Jung P; Bub F; Alhussein F; Benthien S; Berger FK; Berkó-Göttel B; Eisenbeis J; Hahn D; Halfmann A; Last K; Linxweiler M; Lohse S; Papan C; Pfuhl T; Rissland J; Roth S; Schlotthauer U; Utzinger J; Smola S; Gärtner BC; Becker SL
    Ann Glob Health; 2020 Nov; 86(1):148. PubMed ID: 33262937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mass population screening for SARS-CoV-2 and false positives-why Liverpool shows we have a problem.
    Cook D
    BMJ; 2020 Dec; 371():m4954. PubMed ID: 33384318
    [No Abstract]   [Full Text] [Related]  

  • 14. Strategic testing approaches for targeted disease monitoring can be used to inform pandemic decision-making.
    Nichols JD; Bogich TL; Howerton E; Bjørnstad ON; Borchering RK; Ferrari M; Haran M; Jewell C; Pepin KM; Probert WJM; Pulliam JRC; Runge MC; Tildesley M; Viboud C; Shea K
    PLoS Biol; 2021 Jun; 19(6):e3001307. PubMed ID: 34138840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trends in adaptation of fifteen European countries population to SARS-CoV-2 in March-May 2020: Can Taiwanese experience be adopted?
    Sharov KS
    J Formos Med Assoc; 2021 Jan; 120(1 Pt 3):679-687. PubMed ID: 32798031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Proposed COVID-19 Testing Algorithm.
    Hart A; Bortolin M; Awoniyi O; Alhajjaj F; Ciottone GR
    Disaster Med Public Health Prep; 2020 Oct; 14(5):e11-e15. PubMed ID: 32576313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A network-based model to explore the role of testing in the epidemiological control of the COVID-19 pandemic.
    Cui Y; Ni S; Shen S
    BMC Infect Dis; 2021 Jan; 21(1):58. PubMed ID: 33435892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of Containment Measures Against COVID-19 in Singapore: Implications for Other National Containment Efforts.
    Pung R; Cook AR; Chiew CJ; Clapham HE; Sun Y; Li Z; Dickens BL; Ma S; Mak K; Tan CC; Heng D; Chen MI; Lee VJ
    Epidemiology; 2021 Jan; 32(1):79-86. PubMed ID: 33044319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Semiparametric Bayesian inference for the transmission dynamics of COVID-19 with a state-space model.
    Zhou T; Ji Y
    Contemp Clin Trials; 2020 Oct; 97():106146. PubMed ID: 32947047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Travel restrictions and lockdown during the COVID-19 pandemic-impact on notified infectious diseases in Switzerland.
    Steffen R; Lautenschlager S; Fehr J
    J Travel Med; 2020 Dec; 27(8):. PubMed ID: 33152761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.